You are viewing the "Drug Prices" Archives
Health and Human Services outlined two pathways for importing the drugs to the U.S., a plan Secretary Alex Azar says is intended to “lower prices and reduce out of pocket costs for American patients.”
A new lawsuit brought by 44 states and Puerto Rico alleges an “industry-wide” conspiracy by generic drug manufacturers to collude on prices and divide up the market.
The government wants consumers to have sticker shock about drug prices. A new rule requires list prices be displayed in TV ads. Patients advocates are not sure it will do much to lower prices.
The Trump administration wants to increase transparency in prescription drug pricing. But health economists say the administration’s call to tie prices to what other nations pay might work better.
Pharmacy benefit managers are the focus of proposed regulations that could reduce drug costs for seniors and cut profits for middlemen. It could set a precedent for the broader market.
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes and 26 when he died. He couldn’t afford $1,300 per month for his insulin and other diabetes supplies, so he tried to stretch the doses.
The pharmaceutical company Pfizer says it will delay price increases that went into effect on July 1. The move follows pressure from President Trump, who posted a critical tweet on Monday.